期刊文献+

2014-2016年某医院耐碳青霉烯类鲍曼不动杆菌的临床分布和耐药性分析 被引量:14

Analysis of clinical distribution and drug resistance of carbapene-resistant Acinetobacter baumannii in a hospital between 2014 and 2016
原文传递
导出
摘要 目的了解耐碳青霉烯类鲍曼不动杆菌(CRAB)的临床分布和耐药性变化。方法收集2014年1月-2016年12月住院患者的CRAB菌株数据,描述其临床分布,并用WHONET软件进行耐药性分析。结果 1 182株非重复分离的鲍曼不动杆菌中,检出CRAB 514株,其中CRAB感染菌株367株; 2014-2016年CRAB感染检出率逐年上升; CRAB标本多来源为痰液,占61. 31%; CRAB感染部位主要集中在下呼吸道,占47. 1%; CRAB感染菌株主要分布在神经外科、胸外科、急诊科、普外科胃肠和呼吸科,占59. 67%; 3年间CRAB对哌拉西林/他唑巴坦、头孢哌酮/舒巴坦和复方新诺明的耐药率呈逐年下降趋势。结论 CRAB感染主要发生在神经外科和胸外科等科室的下呼吸道感染病例中,CRAB对抗菌药物的耐药率均较高,采取合理的抗菌药物管理措施可降低其耐药性。 Objective To describe the clinical distribution and the drug resistance of Carbapene-resistant Acinetobacter Baumannii( CRAB). Methods During January 2014-December 2016,we collected CRAB data of clinical specimens among hospitalized patients,described the clinical distribution and analyzed it with WHONET software. Results There were1182 strains of Acinetobacter Baumannii in all. 514 strains were CRAB,among which 367 strains were infected strains. During the three years,the proportion of CRAB infected strains among all the Acinetobacter Baumannii grew up significantly each year( χ2= 20. 647,P 0. 001); the sputum accounted for 61. 31%,which was the most in all the clinical samples; the infection site focused on the low respiratory tract,which accounted for 47. 1%; 59. 67% of the infected CRAB strains came from Department of Neurosurgery,thoracic surgery,emergency department,Gastroenterological Surgery and department of Respiration. The drug resistant rates of Piperacillin/tazobactam,Cefoperazone/sulbactam and compound sulfamethoxazole were highest in 2014 and went down each year significantly. Conclusion Most of the CRAB infection happen in the low respiratory tractost of the patients from epartment of Neurosurgery,thoracic surgery,and so on. The drug-resistant rates of bacteria high for CRAB. Rational management measures can help reduce the rate.
作者 朱秋丽 卫菊 胡丹 陈海威 车咏梅 孙喆 ZHU Qiuli;WEI Ju;HU Dan;CHEN Hai-wei;CHE Yong-mei;SUN Zhe(Shanghai First People's Hospital,Shanghai 200080,China)
出处 《中国消毒学杂志》 CAS 2018年第11期856-858,共3页 Chinese Journal of Disinfection
关键词 耐碳青霉烯类鲍曼不动杆菌 分布 耐药 Carbapene - resistant Acinetobacter Baumannii distribution resistance
  • 相关文献

参考文献4

  • 1胡付品,郭燕,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,郭素芳,魏莲花,邹凤梅,张泓,王春,胡云建,艾效曼,卓超,苏丹虹,汪瑞忠,房华,俞碧霞,赵勇,龚萍,郭大文,赵金英,刘文恩,李艳明,金炎,邵春红,温开镇,张贻荣,徐雪松,鄢超,喻华,黄湘宁,王山梅,楚亚菲,张利侠,马娟,周树平,周艳,朱镭,孟晋华.2016年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2017,17(5):481-491. 被引量:778
  • 2刘又宁,曹彬,王辉,陈良安,佘丹阳,赵铁梅,梁志欣,孙铁英,李燕明,童朝晖,王臻,贺蓓,杨薇,瞿介明,李向阳,陈荣昌,叶枫,康健,李尔然,陈萍,郑岩,马忠森,任锦,施毅,孙文逵,冯玉麟,范红,姜淑娟,张嵩,熊盛道,左鹏,王占伟.中国九城市成人医院获得性肺炎微生物学与临床特点调查[J].中华结核和呼吸杂志,2012,35(10):739-746. 被引量:139
  • 3陈佰义,何礼贤,胡必杰,倪语星,邱海波,石岩,施毅,王辉,王明贵,杨毅,张菁,俞云松.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中国医药科学,2012,2(8):3-8. 被引量:513
  • 4习慧明,徐英春,朱德妹,汪复,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳,俞云松,杨青.2010年中国CHINET鲍曼不动杆菌耐药性监测[J].中国感染与化疗杂志,2012,12(2):98-104. 被引量:212

二级参考文献65

  • 1张小江,徐英春,俞云松,杨青,汪复,朱德妹,倪语星,孙景勇,孙自镛,简翠,胡云建,艾效曼,张泓,李万华,贾蓓,黄文祥,王传清,王爱敏,魏莲花,吴玲,卓超,苏丹虹,张朝霞,季萍,徐元宏,熊自忠,沈继录,单斌,杜艳.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446. 被引量:137
  • 2王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 3Clinical and Laboratory Standards Institute. Performancestandards for antimicrobial susceptibility testing~ twentieth information- al supplement[S]. CLSI, 2010,30 ( 1 ) : M100-S20.
  • 4Peleg AY, Seifert H, Paterson DL. Acinetobacterbauman- nil: emergence of a successful pathogen[J]. Clin Microbiol Rev,2008,21(3) :538-582.
  • 5Choi WS, Kim SH, Jeon EG, et al. Nosoeomial outbreak of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units and successful outbreak control program[J]. J Korean Med Sci,2010, 25(7) :999-1004.
  • 6NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992through June 2003, issued August 2003 [J]. Am J Infect Control, 2003,31 (8) : 481 498.
  • 7Karageorgopoulous DE, Falagas ME. Current control and treatment of multidrug-resistant aclnetobacter baumannii in- fections[J]. Lancet Infect Dis, 2008,8 (12): 751-762.
  • 8Perez F, Hujer AM, Hujer KM, et al. Global Challenge of multidrug-resistant Acinetobacter baumannii [ J ]. Antimicrob Agents Chemother, 2007,51 (10) : 3471-3484.
  • 9Y Doi, Husain S, Potoski BA, et al. Extensively drug-resist- ant Acinetobacter baumannii [J ]. Emerg Infect Dis, 2009,15 (6):980-982.
  • 10Bassetti M, Righi E, Esposito S, et al. Drug treatment for multidrug-resistant Acinetobacter baumannii infections [J]. Future Microbiol, 2008,3 (6) .. 649-660.

共引文献1582

同被引文献111

引证文献14

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部